The ambitions to conduct more clinical research in the UK could be achieved by strategic investment in the clinical research workforce, according to new joint FORUM report, Shaping the future…
Today, the Society has joined partner organisations in the UK research and innovation sector in calling for competitively costed visas for international scientists. The call comes ahead of the…
Are all patients with inflammatory bowel disease (IBD) are psychologically strong enough to endure the sudden onset of a chronic disease? Personally, my answer is no. I was not ready to face a…
Every year, there are approximately 1000 new spinal cord injury (SCI) cases. Currently, more than 40,000 people in the UK live with this debilitating condition, which has no cure – a huge financial…
When we think of pharmacology as a discipline, it’s easy to imagine research careers in a university or industry setting. At public engagement events, it’s not uncommon for pharmacology to be…
The government has published its COVID-19 recovery strategy, ‘Our plan to rebuild’, setting out a series of phases as part of this plan. Phase three recognises the critical importance of accelerating…
A new review, published in the British Journal of Pharmacology, from a team of researchers representing the International Union of Basic and Clinical Pharmacology (IUPHAR), identifies…
During these uncertain times, we are more conscious than ever of our need to support and nurture our pharmacology community. The Society is here for you to facilitate connection with each other, and…
The COVID-19 pandemic is a threat to the health and wellbeing of the individuals we know and love, the systems our collective way of life is built on – and the people who make those systems work. At…
Medicines have been prominent in discussions about the COVID-19 pandemic. There is an urgent need to develop effective treatments to lower risks of developing the disease, reduce morbidity and save…
